10 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

BODY CLOCK STIMPLUS AND STIMPLUS PRO

FDA 510(k)
FDA Class 2 ·Neurology

HARMONY DELIVERY CATHETER SYSTEM

FDA Adverse Event
Malfunction ·MEDTRONIC IRELAND·Product code NPV·February 13, 2026

MODIFICATION TO KSEA ENDOTIP SYSTEM

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

DASH 3000/4000 PATIENT MONITOR

FDA 510(k)
FDA Class 2 ·Cardiovascular

UNKNOWN DEPUY STEM

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL·Product code LZO·April 8, 2013

9900

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·March 23, 2011

SWAN-GANZ CONTINUOUS CARDIAC OUTPUT CATHETER

FDA Adverse Event
Malfunction ·EDWARDS LIFESCIENCES, PR·Product code DYG·May 8, 2008

Medfusion Syringe Pump, Model 4000. The Model 4000 pump is a small, lightweight and portable syringe infusion pump. The pump offers a variety of delivery modes programmable to meet specific patient care needs.

FDA Enforcement
Class I ·Terminated·Smiths Medical ASD Inc.·December 18, 2019

Marathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled selective infusion of physician-specified therapeutics agents such as embolization materials and of diagnostic materials such as contrast media. UltraFlow HPC Flow: The device is intended for the controlled selective infusion of physician-specified pharmacologic agents or contrast media into the distal vasculature of the peripheral and neuroanatomy. It is not intended for use in the coronary vasculature. Catalog No. 105-5055V02 105-5055V02 105-5055V05 105-5065V02 105-5065V05 105-5066V02 105-5066V05

FDA Enforcement
Class I ·Terminated·Micro Therapeutics Inc, Dba Ev3 Neurovascular·November 16, 2016

The Spirit Select Bed, Model 5700 Spirit Plus /with high rail siderail option

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·November 21, 2018